StockTipsArenaBeta

BUY Eris Lifesciences Limited — Prabhudas Lilladher

BUYEris Lifesciences Limited
Eris Lifesciences share price target & all analyst calls

byPrabhudas LilladherHorizon: NA (inferred 1–3 months)9 Jul 2026via Economic Times New Stock Recos

Entry₹1,416Inferred
Target₹1,750
Total upside +23.59% (call closed)
Stop lossNot given
At expiry₹1,155.19 Oct 2026, 3:30 pm
Expired-18.43%
Follow Prabhudas Lilladher for new calls(40% target hit, 10 closed calls)Get alertsWatch ERIS for new buy/sell callsGet alertsSee 39 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 9 Oct 2026
5 supporting6 neutral1 opposing
Supports the BUY call (5)

4 advisors have active long-term BUY calls on this stock

Advisor consensus · adjacent horizon·28 Aug · 1mo ago

Neutral / worth noting (6)

Eris Lifesciences Limited has entered into a term loan agreement with Axis Bank Limited for ₹45,00,00,000. The company stated this is a routine financial adjustment and will not impact the expected Ne

NSE · Agreements·9 Sept · 4w ago

(opens in new tab)
Weighs against the BUY call (1)

Krishnakumar Vaidyanathan has resigned as Executive Director & Chief Operating Officer (COO) of Eris Lifesciences Ltd, effective September 30, 2026, to pursue external professional opportunities. The

BSE · Company Update·11 Sept · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Eris Lifesciences

All analyst calls on Eris Lifesciences

More from Prabhudas Lilladher

Every call and its outcome